The patients with higher levels of CD73 correlated with a poor clinical and biological prognostic factor, and presented a shorter overall survival, supporting the idea that CD73 may play a role in CLL pathophysiology, and may be of potential value as a prognostic marker and therapeutic target [48]. Here, NT5E is linked to B-cell chronic lymphocytic leukemia.